Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial-Reference-Cited by-同舟云学术

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

Published:2002-10 Issue:10 Volume:13 Page:1539-1549
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Rosell R.,Gatzemeier U.,Betticher D.C.,Keppler U.,Macha H.N.,Pirker R.,Berthet P.,Breau J.L.,Lianes P.,Nicholson M.,Ardizzoni A.,Chemaissani A.,Bogaerts J.,Gallant G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/10/1539/400589/mdf332.pdf

Reference29 articles.

1. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer European Organization for research and treatment of cancer protocol 07861;Klastersky;J Clin Oncol,1990

2. Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer;Gatzemeier;J Clin Oncol,2000

3. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

4. Mitomycin ifosfamide and cisplatin in unresectable non-small-cell lung cancer effects on survival and quality of life;Cullen;J Clin Oncol,1999

5. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer sobering results;Breathnach;J Clin Oncol,2001

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study;Pulmonology;2024-04

2. Efficacy Comparison Between Weekly and Triweekly Regimens of Carboplatin-paclitaxel in Non-small Cell Lung Cancer;Namık Kemal Tıp Dergisi;2023-09-15

3. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

4. Novel Approaches in Cancer Treatment: Tumor Targeted Therapy;Handbook of Cancer and Immunology;2023

5. Non-coding RNA-related antitumor mechanisms of marine-derived agents;Frontiers in Pharmacology;2022-12-01